The American Institute for Medical and Biological Engineering (AIMBE), of Washington, D.C., has announced the induction of Lawrence Mayer, founder, president and chief scientific officer of Celator Pharmaceuticals, to its College of Fellows.
Mayer was nominated, reviewed and elected by peers and members of the College of Fellows “for outstanding contributions to the field of nanomedicines and the development of novel pharmaceutical products for cancer and other diseases.”
Mayer, a 1974 graduate of Oconto Falls High School, lives in Vancouver, British Columbia, Canada. He attended Wartbug College in Iowa and received his doctorate from the University of Minnesota. His parents are LaVern and Marilyn Mayer, of Oconto Falls.
The College of Fellows is comprised of the top 2 percent of medical and biological engineers in the country. AIMBE Fellows are regularly recognized for their contributions in teaching, research and innovation.
“AIMBE is a prestigious group that fosters advancement in medical innovation and discovery,” Mayer said. “Being inducted as a Fellow of AIMBE is a great honor.”
“We are excited that Lawrence is being recognized as an innovator in the field of nanomedicines,” said Scott Jackson, CEO of Celator. “He is a driving force behind the company’s technology platforms and the advancement of products into clinical development.”
Celator Pharmaceuticals Inc., with locations in Ewing, New Jersey and Vancouver, is a clinical stage biopharmaceutical company that incorporates traditional chemotherapies as well as molecularly targeted agents to deliver enhanced anti-cancer activity.
A formal induction ceremony was held during AIMBE’s 2015 annual meeting March 16 at the National Academy of Sciences Great Hall in Washington, D.C. Mayer was inducted along with 150 colleagues.
Categories
